- Blog
- News & Media
- Issues
- About The Biopharmaceutical Sector
- Access and Affordability
- Adherence
- Appropriate Use Of Medicines
- Counterfeit Drugs
- Disaster Response
- Drug Safety
- Environmental Issues
- Food And Drug Administration
- Importation
- Intellectual Property
- International
- Medical Advances
- Medicare
- Prescription Drug Abuse
- Prescription Drug User Fee Act
- Sales And Marketing
- Value of Medicines
- Research
- About
Matthias von Herrath of Novo Nordisk discusses the diabetes epidemic and the hope for the future
Vice President and Head of Type 1 Diabetes R&D Center of Novo Nordisk, Matthias von Herrath speaks about diabetes and the importance of collaboration between the biopharmaceutical research industry and the diabetes community.
